NCT04531566

Brief Summary

The purpose of this study is to demonstrate that allowing infants that require high flow nasal cannula (HFNC)/Continuous positive airway pressure (CPAP) to orally feed if demonstrating oral cues will achieve full oral feeds faster.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 28, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 20, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

2.2 years

First QC Date

August 25, 2020

Last Update Submit

May 19, 2022

Conditions

Keywords

PrematurityOral SkillsNasal CPAP oral feedsHFNC oral feeds

Outcome Measures

Primary Outcomes (1)

  • Post menstrual Age (PMA) once full oral feeds are achieved as documented by not requiring gavage tube feeds for at least 24 hours

    Measured in the electronic medical record

    2 months after enrollment

Secondary Outcomes (12)

  • PMA at hospital discharge

    up to 6 months after admission

  • PMA at completion of first oral feed

    1 month after enrollment.

  • length of hospitalization

    up to 6 months after admission

  • number of gastrostomy tube

    up to 6 months after admission

  • oxygen at discharge

    up to 6 months after admission

  • +7 more secondary outcomes

Study Arms (2)

Oral Feed Intervention Group

EXPERIMENTAL
Dietary Supplement: Oral Feed

Usual care

ACTIVE COMPARATOR
Dietary Supplement: Usual care

Interventions

Oral FeedDIETARY_SUPPLEMENT

Infant will be seen by occupational therapist (OT) twice a week and assessed for oral cues. If infant shows oral cues then the occupational therapist will proceed with feeding strategies. Oral feeding strategies include pacifier dips, open nipple trials with syringe controlled bolus size (1-4mls) and po trials up to 10mls.

Oral Feed Intervention Group
Usual careDIETARY_SUPPLEMENT

Infants will not start oral feeds until on HFNC 2 Litres or less. Oral feeds will be started on the discretion of the physician.

Usual care

Eligibility Criteria

Age32 Weeks+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • infants that require greater than 2 litres per minute (LPM) high flow nasal canula or CPAP with a max setting of 6cm H20 FiO2 30% or less for at least 72 hours or more
  • Tolerating enteral feeds of 120 ml/kg/day

You may not qualify if:

  • Major congenital anomalies (pulmonary malformations, airway malformations, craniofacial defects, major congenital heart disease, combined pulmonary intestinal malformations)
  • Metabolic disorder
  • Major gastrointestinal surgeries
  • Patent ductus arteriosus (PDA) ligation surgery
  • Outborn deliveries greater than 7 days old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Ashley N Morin, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fellow

Study Record Dates

First Submitted

August 25, 2020

First Posted

August 28, 2020

Study Start

October 20, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations